Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients



Rating:

Share or cite this content

Citations should be made in the following way:
A. Akhtar (Barnsley (South Yorkshire), United Kingdom), M. Usman (Barnsley (South Yorkshire), United Kingdom), H. Azam (Manchester, United Kingdom). Compliance with BTS and NICE guidelines in assessment of possible pulmonary embolism. 493

Member's Comments

No comment yet.

Related content which might interest you: What is new in the 2019 ESC/ERS guidelines for the management of pulmonary embolism? Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines Year: 2019 Impact of guidelines for the management of pulmonary embolism in clinical practice Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines Year: 2019 The 2014 ESC pulmonary embolism guidelines Source: International Congress 2014 – The ERJ and ERR at the forefront of respiratory medicine: 2014 guidelines Year: 2014 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Source: Guideline 2015 Year: 2021 Management of pulmonary embolism: recent evidence and the new European guidelines Source: Eur Respir J 2014; 44: 1385-1390 Year: 2014 WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension Source: Eur Respir Rev, 31 (163) 210165; 10.1183/16000617.0165-2021 Year: 2022 Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017 Year: 2017 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Source: Eur Respir J, 54 (3) 1901647; 10.1183/13993003.01647-2019 Year: 2019 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Source: Guideline 2019 Year: 2019 Guidelines for the diagnosis and treatment of pulmonary hypertension Source: Guideline 2009 Year: 2009 Guidelines for the diagnosis and treatment of pulmonary hypertension Source: Eur Respir J 2009; 34: 1219-1263 Year: 2009 Recommendations of the ATS/ERS Task Force for the definition of outcomes for COPD pharmacological trials Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Pulmonary hypertension: new guidelines for therapy Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007 Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre Source: Guideline 2009 Year: 2009 Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre Source: Eur Respir Rev 2009; 18: 272-290 Year: 2009 Compliance with recommendation for respiratory sampling in diagnosis of Tuberculosis(NICE guideline NG33) Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Guideline methodology in the ERS/ATS COPD exacerbation guidelines Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 The cost of pulmonary embolism treatment with different anticoagulation strategies in Turkey Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Contact tracing in pulmonary versus non-pulmonary tuberculosis- the impact of the 2016 NICE guidelines? Source: International Congress 2017 – Migrants and screening Year: 2017